Cancer risk in inherited bone marrow failure syndromes
Part of Blood & lymphatic, Digestive system, Genetic & congenital, Hormones & metabolism, Skin clinical trials.
This study looks at why people with inherited bone marrow failure syndromes (rare genetic conditions affecting blood cell production) have higher cancer risk. Researchers want to understand the genetic and medical factors that increase cancer likelihood, which could help doctors monitor and protect affected patients and their families.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have one of these inherited bone marrow failure syndromes: Fanconi anemia, Diamond Blackfan anemia, dyskeratosis congenita, Shwachman Diamond Syndrome, severe congenital neutropenia, or a similar condition—OR you are a blood relative of someone with one of these conditions
- Your bone marrow disorder is genetic (inherited), not caused by drugs, toxins, infections, or other acquired conditions
- You do not have other known causes of low blood cell counts, such as autoimmune disease, hepatitis, vitamin deficiencies, or cyclic neutropenia
- You or your legal guardian can understand and sign informed consent to participate
- You are willing to allow researchers to access your medical records and tissue samples for study purposes
- You are any age, from birth through old age, and any race or ethnicity
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study screens individuals who may have a genetic condition that increases cancer risk. It looks for certain inherited syndromes, like Li-Fraumeni syndrome, RASopathies, or bone marrow failure syndromes, and helps determine if further genetic testing or cancer monitoring is needed.
This study looks at how squamous cell carcinoma (a type of cancer) naturally develops over time in people with Fanconi anemia. It may help doctors better recognize warning signs and plan care in the future.
This study looks at genetic (DNA) factors that may contribute to certain blood disorders. You may be invited if you or a close family member is receiving care for a blood condition like MDS or MPN, and the study also includes related relatives.
This trial is a global survey and registry for people with Shwachman-Diamond Syndrome and related inherited blood disorders. It aims to connect patients, families, and researchers to better understand these conditions and improve care.
This study looks at inherited (family) risk for childhood cancers, including families with early cancers or known cancer risk conditions. It may help researchers understand why some children get cancer and improve future risk detection and care.
This study uses advanced genetic testing to look at the DNA of children with Fanconi anemia and their parents. The goal is to learn more about the genetic causes of the condition, which might help guide future care.
Hear when a new Diamond Blackfan Anemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.